Our Work

Since day one, dQ&A has elevated diabetes patient voices—explore our infographic to see how these insights have shaped client decisions over the years.

Our quarterly U.S. diabetes survey found one-third of respondents had mild or severe depression, underscoring the need for more support and better treatments.

Erik Shoger presented real-world patient insights at the FDA advisory meeting on sotagliflozin, highlighting the need for education and training if approved.

We invite you to watch this 4-minute selfie video reel featuring real people describing their very real struggles with diabetes.

Our research explores the connection between time-in-range and mental health in people with type 1 and type 2 diabetes.

Our research reveals low awareness of DKA and ketone testing among type 2 diabetes patients on SGLT2 inhibitors, highlighting urgent education needs.

Our research found that social stigma perceptions were more common in type 1 diabetes than type 2, possibly because type 2 is less visible.